ZAMBROTTA, GIOVANNI PAOLO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 505
EU - Europa 299
AS - Asia 120
SA - Sud America 2
AF - Africa 1
Totale 927
Nazione #
US - Stati Uniti d'America 503
IT - Italia 96
DE - Germania 76
SG - Singapore 54
IE - Irlanda 45
CN - Cina 28
RU - Federazione Russa 25
SE - Svezia 23
ID - Indonesia 16
GB - Regno Unito 10
HK - Hong Kong 10
CZ - Repubblica Ceca 5
FI - Finlandia 5
IN - India 4
DK - Danimarca 3
TR - Turchia 3
AT - Austria 2
CA - Canada 2
FR - Francia 2
JP - Giappone 2
UA - Ucraina 2
BG - Bulgaria 1
BR - Brasile 1
CO - Colombia 1
IR - Iran 1
LT - Lituania 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
VN - Vietnam 1
Totale 927
Città #
Ann Arbor 228
Frankfurt am Main 57
Milan 45
Dublin 44
Singapore 44
Chandler 29
Ashburn 27
Wilmington 27
Fairfield 24
Santa Clara 22
Houston 16
Jakarta 16
New York 16
Hong Kong 10
Cambridge 9
Seattle 9
Princeton 8
Altamura 7
Lodi 7
Woodbridge 7
Shanghai 6
Beijing 5
Brno 5
Dearborn 5
Guangzhou 5
Lawrence 4
Washington 4
Ankara 3
Cinisello Balsamo 3
Helsinki 3
Munich 3
Romola 3
Bonndorf 2
Cruseilles 2
Fremont 2
Grafing 2
Jamaica Plain 2
Lappeenranta 2
Moscow 2
Nichelino 2
Nova Milanese 2
Sapporo 2
Shenyang 2
Vienna 2
Acton 1
Andover 1
Boardman 1
Bogotá 1
Bologna 1
Carate Brianza 1
Cardano al Campo 1
Chaoyang 1
Chicago 1
Como 1
Dallas 1
Desio 1
Edmonton 1
Esslingen am Neckar 1
Falls Church 1
Hanoi 1
Jacksonville 1
Katy 1
Kilburn 1
Los Angeles 1
Manila 1
Nanchang 1
Nanjing 1
Novokuznetsk 1
Ottawa 1
Oxford 1
Padova 1
Phoenix 1
Redmond 1
Rome 1
Sacramento 1
San Mateo 1
Segrate 1
Stockholm 1
Taizhou 1
Tianjin 1
Trumbull 1
Vijayawada 1
Weifang 1
Zhengzhou 1
Totale 765
Nome #
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 273
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 256
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 239
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study 87
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 56
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape 37
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production 37
Totale 985
Categoria #
all - tutte 3.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 6 12 4 5 8 5 0
2020/2021262 1 3 9 7 9 9 85 43 27 20 28 21
2021/2022152 22 20 18 17 18 10 0 4 5 5 14 19
2022/2023175 19 46 18 10 18 21 3 11 12 0 11 6
2023/2024171 3 6 7 19 27 40 28 6 13 5 2 15
2024/2025140 16 22 28 24 32 18 0 0 0 0 0 0
Totale 985